methylphenidate has been researched along with Basal Ganglia Diseases in 4 studies
Methylphenidate: A central nervous system stimulant used most commonly in the treatment of ATTENTION DEFICIT DISORDER in children and for NARCOLEPSY. Its mechanisms appear to be similar to those of DEXTROAMPHETAMINE. The d-isomer of this drug is referred to as DEXMETHYLPHENIDATE HYDROCHLORIDE.
methylphenidate : A racemate comprising equimolar amounts of the two threo isomers of methyl phenyl(piperidin-2-yl)acetate. A central stimulant and indirect-acting sympathomimetic, is used (generally as the hydrochloride salt) in the treatment of hyperactivity disorders in children and for the treatment of narcolepsy.
methyl phenyl(piperidin-2-yl)acetate : A amino acid ester that is methyl phenylacetate in which one of the hydrogens alpha to the carbonyl group is replaced by a piperidin-2-yl group.
Basal Ganglia Diseases: Diseases of the BASAL GANGLIA including the PUTAMEN; GLOBUS PALLIDUS; claustrum; AMYGDALA; and CAUDATE NUCLEUS. DYSKINESIAS (most notably involuntary movements and alterations of the rate of movement) represent the primary clinical manifestations of these disorders. Common etiologies include CEREBROVASCULAR DISORDERS; NEURODEGENERATIVE DISEASES; and CRANIOCEREBRAL TRAUMA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pérez, CA | 1 |
| Garcia, SS | 1 |
| Yu, RD | 1 |
| Tahiroglu, AY | 1 |
| Avci, A | 1 |
| Kudrin, AN | 1 |
| Davydova, ON | 1 |
| Krendal', FP | 1 |
| Fann, WE | 1 |
| Davis, JM | 1 |
| Wilson, IC | 1 |
1 trial available for methylphenidate and Basal Ganglia Diseases
| Article | Year |
|---|---|
Methylphenidate in tardive dyskinesia.
Topics: Administration, Oral; Basal Ganglia Diseases; Clinical Trials as Topic; Evaluation Studies as Topic; | 1973 |
3 other studies available for methylphenidate and Basal Ganglia Diseases
| Article | Year |
|---|---|
Extrapyramidal Symptoms as a Result of Risperidone Discontinuation During Combination Therapy with Methylphenidate in a Pediatric Patient.
Topics: Adolescent; Antipsychotic Agents; Basal Ganglia Diseases; Central Nervous System Stimulants; Drug Th | 2016 |
Imipramine, methylphenidate and valproic acid-related EPS in a child: a case report.
Topics: Basal Ganglia Diseases; Child; Female; Humans; Imipramine; Methylphenidate; Valproic Acid | 2007 |
[Pharmacologic incompatibility of neuroleptics and tranquilizers with other medicines].
Topics: Amphetamine; Animals; Anti-Anxiety Agents; Anti-Arrhythmia Agents; Anticonvulsants; Antipsychotic Ag | 1977 |